Testing a new insulin in healthy men
Part of Hormones & metabolism clinical trials.
This study tests if a new insulin injection made with different manufacturing methods works the same in the body. Healthy men aged 18-50 can join to help check if the new versions are as good as the original.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 50 years old.
- You weigh at least 110 pounds and have a body mass index (BMI) between 18.5 and 24.0.
- You are willing to get insulin injections and follow the study rules.
- You agree to use birth control and not donate sperm for 4 weeks after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new weekly insulin called GZR4 for people with type 2 diabetes who already use basal insulin. It aims to see how well it controls blood sugar and if it is safe.
This study tests a new once-daily insulin (GZR4) against an approved insulin (degludec) in people with type 2 diabetes to see how well it controls blood sugar. You may qualify if you are already using a stable dose of background insulin.
This study tests whether a change in the manufacturing process for GZR18 (an experimental injectable drug) affects how it works in the body. It may help determine if the new version is as safe and effective as the original.
This trial tests how a single injection of a new drug called GZR4 is absorbed when given at different injection sites (like the belly or thigh) in healthy men. It helps researchers understand how the drug works in the body before testing it in people with diabetes.
This trial tests an experimental insulin (GZR101-80) to see if it helps control blood sugar in people with type 2 diabetes. You may join if you’ve had type 2 diabetes for at least 6 months and are between 18 and 75 years old.
This trial tests a new injection (GZR102) compared to two other injections (GZR4 and GZR18) in overweight adults. The goal is to see how well the body processes each drug and their effects. It may help researchers find a better treatment for weight management.
Hear when a new T2D trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.